HHealth Read More RFK Jr.’s vaccine panel to vote on hepatitis B shot for babiesDecember 4, 2025 U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. looks on as he attends a press…
HHealth Read More FDA removes Office of Nonprescription Drugs Director Theresa MicheleDecember 3, 2025 WASHINGTON — The Food and Drug Administration removed the longtime director of the office of over-the-counter drugs from…
MMedication Read More FDA reviewers didn’t get to vote on first priority voucher drugNovember 21, 2025 WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
HHealth care Read More Eli Lilly hits $1 trillion market value, first for health care companyNovember 21, 2025 A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
HHealth Read More CDC changes vaccine safety web page to include debunked claimsNovember 20, 2025 WASHINGTON — The Centers for Disease Control and Prevention on Wednesday publicly reversed its stance that vaccines do…
HHealth care Read More Novo Nordisk cuts cash prices for Wegovy, OzempicNovember 17, 2025 Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…
HHealth care Read More Trump deals with Lilly, Novo Nordisk could broaden obesity drug accessNovember 8, 2025 US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC…
HHealth care Read More Trump strikes deal with Eli Lilly, Novo NordiskNovember 6, 2025 Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
HHealth care Read More Omada Health to start prescribing GLP-1s, other obesity medicationsNovember 6, 2025 The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Virtual…
MMedication Read More Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s StelaraNovember 6, 2025 In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…